OATP1A2 |
Blood-brain barrier |
10,11
|
Expressed in bone cancer tissues and cell lines |
49
|
|
Kidney |
11
|
Reduced in colon polyps and cancer |
44
|
|
Cholangiocytes |
11 |
|
|
|
Enterocytes |
12 |
Increased in breast carcinoma cells and malignant breast tissue |
45,46
|
|
OATP1B1 |
Liver |
13,14,17
|
Reduced in hepatocellular carcinoma |
50--53, 55, 56
|
|
OATP1B3 |
Liver |
15, 18
|
Reduced in hepatocellular carcinoma |
54
|
|
|
|
Expressed in: Colorectal adenocarcinoma tissues |
58
|
|
|
|
Non-small-cell lung tumors |
50
|
|
|
|
Prostate cancer tissue |
60,61
|
|
|
|
Invasive ductal carcinoma breast cells |
62
|
|
|
|
Cell lines of stomach, colon, pancreatic, and gall bladder cancers |
13
|
|
OATP1C1 |
Brain |
23
|
Expressed in bone cancers |
49
|
|
Testes |
20
|
|
|
|
Ciliary body |
24
|
|
|
|
OATP2A1 |
Ubiquitous |
25--28
|
Increased in malignant breast tissue and liver cancers |
47,64
|
|
|
|
Reduced in tumors of bowel, stomach, ovary, lung, and kidney |
63
|
|
OATP2B1 |
Liver |
29a
|
Increased in bone cysts |
49
|
|
Blood-brain barrier |
31
|
Altered in breast cancers |
47,65
|
|
Enterocytes |
30
|
|
|
|
Placenta |
34
|
|
|
|
Heart |
32
|
|
|
|
OATP3A1 |
Ubiquitous |
35--37
|
Expressed in bone cancer and |
49
|
|
|
|
Cancer cell lines of multiple tissues |
29, 33, 37, 66, 67
|
|
OATP4A1 |
Ubiquitous |
29, 39, 40
|
Expressed in bone cancer and |
49
|
|
|
|
Cancer cell lines of multiple tissues |
29, 33, 47, 66
|
|
OATP4C1 |
Kidney |
41
|
|
|
|
OATP5A1 |
Lactiferous ducts in breast |
37
|
Expressed in malignant breast tumors |
37
|
|
OATP6A1 |
Testes |
42,43
|
Expressed in tumors of the lung, bladder, and esophagus |
42
|